“Man is as old as his arteries.” –Thomas Sydenham Cardiovascular diseases are commonly associated with unhealthy lifestyles. Do you know that age is a strong predictor of cardiovascular diseases in both men and women? As you grow older, your risks of suffering a heart attack, to have a stroke, or to develop coronary heart disease … Read more
Your cancer treatment may be over, but does it continue to cause side effects to your body? Chemotherapy and radiation have revolutionized the survival rates among cancer patients, but so is the development of cardiovascular diseases (CVD) in cancer survivors. The scientific session 2021 program committee organized an educational session on cardio-oncology, which included talks … Read more
One of the hot topics from this year’s AHA21 Scientific Sessions main event was how to promote healthy vascular aging. Age is the strongest predictor for cardiovascular (CV) risk and risk factors such as genetic predisposition and hyperlipidemia increase CV risk. The general recommendations to reduce CV risk were elegantly presented by Dr Roger S. … Read more
Over 50 emerging scientists and clinicians were among the finalists of the Early Career Investigator Award in AHA Scientific Sessions 2021. These prestigious awards were designed to recognize the marvelous endeavors by early career investigators who submitted their abstracts to AHA Scientific Sessions 2021. The selection process included not only the quality of the abstracts … Read more
The most anticipated cardiovascular conference of the year, AHA Scientific Sessions 2021 is upon us! In the days and hours leading upto the event, speakers have been revising their presentations, moderators going over their notes, and organizers working hard to prevent any glitches for this fully virtual experience. For many attendees, including myself, the most … Read more
If you didn’t tune into #AHA21 “Novel Strategies to Promote Healthy Vascular Aging,” you missed an exciting area of health and wellness that many of us care about: how can we and our patients live longer with reduced cardiovascular disease burden? The AHA makes it “simple” with Life’s Simple 7 that includes 1) managing blood … Read more
While AHA Meetings are highly valued for their annually impressive original science presented to conference goers, these annual meetings also provide much sought-after space for highlighting and amplifying voices within cardiovascular research that historically have not been given center-stage. Over the past few years, the “Women In Science” and the “Early Career Networking” sessions have … Read more
ST-elevation myocardial infarction (STEMI) is considered a medical emergency globally, where the patient must seek medical help immediately. The treatment plan for this condition involves reperfusion therapy with or without stent placement, controlling the comorbidities and using specific medications to reduce the risk of recurrence and future complications. One of the major drug categories is … Read more
Earlier this year, The American Heart Association and the California Walnut Commission (CWC), a non-profit organization funded by mandatory assessments of the growers, announced a special award to support early career scientists pursuing human clinical or epidemiological research on walnut consumption.1 This presents an exciting opportunity to engage early scientists interested in improving public health … Read more
Gestational Hypertension (GHTN) is defined as the new onset of systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg , on at least 2 occasions 4 hours apart , at or after 20 weeks of gestation in a previously normotensive woman . It is considered as one type of the major hypertensive disorders … Read more